X-Energy Beats Loss Estimates as Revenue Doubles to $66.3 Million

X-Energy (NASDAQ:XE) reported a loss of $0.14 per share for the quarter, beating the consensus estimate of a $0.21 loss by $0.07, according to FiscalAI. Revenue reached $66.34 million, up 118.1 percent year over year, a figure the company achieved before earning a single dollar from commercial reactor operation.

The numbers arrive with a familiar shape for pre-revenue nuclear developers: fast top-line growth, faster spending. Operating expenses rose 139 percent to $169.9 million, and operating activities consumed $51.2 million in cash during the quarter. The balance sheet remains the argument for patience. X-Energy holds $1.8 billion in cash and investments and carries no debt.

What did the regulator decide?

The Nuclear Regulatory Commission (NRC, the U.S. nuclear regulator) issued a construction permit for Dow's Long Mott project more than a month ahead of schedule. X-Energy said the milestone could help streamline later applications, an unusually concrete benefit from a regulator not known for early deliveries. Dow still must make its investment decisions, with a preliminary decision expected in 2027.

The Xe-100 design also entered the United Kingdom's Generic Design Assessment, the British pre-licensing review of reactor designs, extending the company's regulatory reach across two jurisdictions at once.

How large is the commercial pipeline?

X-Energy, AEP and Amazon agreed to advance development of a proposed 960-MW, twelve-reactor project in Indiana. The work remains at an early stage and includes site studies and preparation for a future permit application. Pipelines are not orders. Still, a twelve-reactor commitment from a utility and a hyperscaler is the sort of early-stage work investors price now and verify later.

The company also completed exterior construction of the TX-1 fuel facility on schedule and is moving into interior work and equipment installation. X-Energy holds an NRC license to manufacture TRISO-X fuel (pebble-shaped fuel engineered to retain radioactive materials at high temperatures) and aims to serve customers beyond its own reactor fleet. XTAC renovations and testing are intended to reduce manufacturing and operating risks ahead of deployment.

How did the market react?

Shares traded up $0.56 on Thursday to $11.50, on volume of 4,061,420 shares against an average of 5,990,935. The stock has a 52-week range of $8.68 to $37.10, a spread that tells its own story. The market capitalization stands at $4.67 billion, with a price-to-earnings ratio of -76.67 and a 50-day moving average of $13.48.

What do analysts say?

The sell side is divided, to put it politely:

• Piper Sandler cut its price objective from $9.00 to $8.00 and set an "underweight" rating on October 19.
• Weiss Ratings initiated coverage with a "sell (d)" rating on July 20.
• Texas Capital raised the stock to "strong-buy" on September 14.
• Cantor Fitzgerald reaffirmed "overweight" with a $38.00 target on August 14.
• Morgan Stanley lowered its target from $41.00 to $34.00, keeping "overweight," on October 14.

According to MarketBeat.com, the consensus rating is "Moderate Buy" with an average price target of $29.67. One analyst rates the stock Strong Buy, seven rate it Buy, four Hold and two Sell.

Who is buying the shares?

Institutional activity skewed small and new. Eastern Bank acquired a stake of roughly $28,000 in the third quarter; GK Wealth Management about $57,000; Mitsubishi UFJ Morgan Stanley Securities approximately $130,000. IFP Advisors and Silicon Valley Capital Partners bought stakes of about $95,000 and $103,000, respectively, in the second quarter. These are toe-dips, not commitments.

What is the verdict?

X-Energy, founded in 2009, develops small modular reactors and fuel; its Xe-100 is a high-temperature, gas-cooled reactor intended for electricity and industrial process heat. The quarter delivered a narrower-than-expected loss, doubled revenue, a five-year balance sheet runway and genuine regulatory progress. It also delivered opex growing faster than revenue. For a company whose product remains years from commercial operation, that trade-off is the whole investment case.